Protein Information

ID 499
Name kallikrein
Synonyms KLK 1; HK1; KLK1; KLKR; Kallikrein; Kallikrein 1; Kallikrein 1 isoform 3 preproprotein; Kallikrein serine protease 1…

Compound Information

ID 1408
Name diatomaceous earth
CAS diatomite

Reference

PubMed Abstract RScore(About this table)
11684986 Avidan MS, Da Fonseca J, Parmar K, Alcock E, Ponte J, Hunt BJ: The effects of aprotinin on thromboelastography with three different activators. Anesthesiology. 2001 Nov;95(5):1169-74.
BACKGROUND: Thromboelastography is used for assessment of hemostasis. Adherence to thromboelastography-guided algorithms and aprotinin administration each decrease bleeding and blood product usage after cardiac surgery. Aprotinin, through inhibition of kallikrein, causes prolongation of the celite-activated clotting time and the activated partial thromboplastin ratio. The aim of this study was to assess the effects of aprotinin on the thromboelastography trace. METHODS: Three activators were used in the thromboelastography: celite (which is widely established), kaolin, and tissue factor. Assessment was performed on blood from volunteers and from patients before and after cardiac surgery. RESULTS: The tissue factor-activated thromboelastography trace was unaffected by the addition of aprotinin. When celite and kaolin were used as activators in the presence of aprotinin, the reaction time (time to clot formation) of the thromboelastography trace was prolonged (P < 0.0001) and the maximum amplitude (clot strength) was decreased (P < 0.05). With celite as an activator, the addition of aprotinin decreased (P < 0.05) the thromboelastography alpha angle (rate of clot extension). The reaction time of the celite-activated trace correlated with the activated partial thromboplastin ratio (P < 0.01). The reaction time of the tissue factor-activated trace correlated with the international normalized ratio (P < 0.01). CONCLUSION: The thromboelastography trace is altered in the presence of aprotinin when celite and kaolin are used as activators but not when tissue factor is the activator.
1(0,0,0,1)